Biobank
/
Eastern Norway
Post Views: 0

Bionor Pharma Asa

Export Market

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia

Additional Information

  • Finance
    Total revenue: 1.851
    Operating profit: -12.95
    Operating profit before tax: -55.608
    Total assets: 1.430.020
    Total equity: 1.424.547
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Simen Thorsen


    Board Members:
    Bente M Søfteland Bøhler
    Heidi Sørensen Austbø
    Runar Vatne
    Sofia Katarina Finneng
    Tore Aksel Voldberg
    Øystein Arnulf Landvik



    General Manager:
    Andreas Martinussen


    Subsidiary companies:
    Largest shareholders:
    N/A

KEYWORDS

    Biobank, Biotechnology, Health Care, Pharmacological Treatments (New Medicines & Therapies), Terapeutica, Therapeutic agents,

Related Companies

Featured

Norwegian Special Mission signs contract with Textron Aviation

Featured

Global Trade AS Eastern Norway

Global Trade is a international seafood trading specialist. Quality and freshness is their concern no.1. Buy fish directly...

Featured

Norsk Hydro Asa

Contact
info@norwayexports.no
08.00 - 16.00
Your gateway to the Norwegian export market
Search Norway's largest database of exporters:
• 35 business sectors
• 2000 product groups
• 8000 products & services
• Companies, trademarks, products or services
SINCE 1957
javo-footer-info-image
© 2020 | By Medievekst AS
X